Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Identifies Non-Smokers at High Risk for Lung Cancer from Single Chest X-Ray

By MedImaging International staff writers
Posted on 08 Dec 2023

Lung cancer is currently the leading cause of cancer mortality. Notably, 10-20% of lung cancer cases are diagnosed in individuals classified as "never-smokers" – those who have either never smoked or have smoked fewer than 100 cigarettes in their lifetime. The prevalence of lung cancer in never-smokers is increasing, and these cases are often more advanced at the time of discovery due to the lack of early detection methods typically used for smokers. Now, a new study has found that an artificial intelligence (AI) tool is capable of identifying non-smokers at high risk for lung cancer by analyzing routine chest X-ray images.

Conducted by the Massachusetts General Hospital (MGH, Boston, MA, USA), this study aimed to enhance the prediction of lung cancer risk in never-smokers. The research team employed a deep learning model, a sophisticated form of AI, to analyze chest X-ray images from the electronic medical record, searching for patterns indicative of disease. The deep learning model, named "CXR-Lung-Risk," was trained using 147,497 chest X-rays from 40,643 asymptomatic individuals, both smokers and never-smokers. This model was designed to assess lung-related mortality risk from a single chest X-ray.

The effectiveness of the model was then tested on a separate cohort of never-smokers who underwent routine outpatient chest X-rays between 2013 and 2014. The primary measure was the incidence of lung cancer within six years, identified via International Classification of Disease codes. The model categorized the risk scores into low, moderate, and high-risk groups based on predetermined risk thresholds. In the study group of 17,407 patients, averaging 63 years of age, the model classified 28% as high risk, and within this group, 2.9% later had a diagnosis of lung cancer. The high-risk group surpassed the 1.3% six-year risk threshold where lung cancer screening CT is recommended by the US National Comprehensive Cancer Network guidelines. After taking into account age, sex, race, previous lower respiratory tract infection, and prevalent chronic obstructive pulmonary disease, the high-risk group still had a 2.1 times greater risk of developing lung cancer than the low-risk group.

"This AI tool opens the door for opportunistic screening for never-smokers at high risk of lung cancer, using existing chest X-rays in the electronic medical record," said senior author Michael T. Lu, M.D., M.P.H., director of artificial intelligence and co-director of CIRC at MGH. "Since cigarette smoking rates are declining, approaches to detect lung cancer early in those who do not smoke are going to be increasingly important."

Related Links:
MGH

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Mobile Digital C-arm X-Ray System
HHMC-200D
New
X-Ray QA Meter
Piranha CT
New
Compact C-Arm
Arcovis DRF-C S21
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.